Rapamycin powders for pulmonary delivery
US9387169B2 · kind B2 · utility
6Cited by
62References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 6, 2015 |
| Grant date | Jul 12, 2016 |
| Priority date | — |
| Expiry date | Nov 6, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/436
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides stable, spray-dried, particle formulations containing rapamycin, or pharmaceutically acceptable salts of rapamycin, which are useful for pulmonary administration to the respiratory tract of a patient for the treatment of disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.